{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:19:27Z","timestamp":1788283167839,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T00:00:00Z","timestamp":1712880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neurot.2024.e00363","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T05:03:35Z","timestamp":1715058215000},"page":"e00363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study"],"prefix":"10.1016","volume":"21","author":[{"given":"Clara G.","family":"Chisari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Aguglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bergamaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Brescia","family":"Morra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cavalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cottone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Di Sapio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Granella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Lus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Maimone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia Teresa","family":"Maniscalco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girolama","family":"Marfia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Moiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Paolicelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Pesci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rovaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Solaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Totaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Trojano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika","family":"Vianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Zaffaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Lepore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6923-0846","authenticated-orcid":false,"given":"Francesco","family":"Patti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Balgera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Banfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bellantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Placido","family":"Bramanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Cavalletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Chiveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Clerico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Corea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Dattola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Robertis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Di Battista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Galgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia","family":"Gatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Lo Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Ottavio","family":"Logullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Protti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Rezzonico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosa","family":"Rottoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Salvetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Scarpini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Sparaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Spitaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Tassinari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Tonietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Valzania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Venturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurot.2024.e00363_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00363_bib2","doi-asserted-by":"crossref","first-page":"A387","DOI":"10.1016\/j.autrev.2009.11.010","article-title":"Multiple sclerosis: geoepidemiology, genetics and the environment","volume":"9","author":"Milo","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00363_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2008-1040881","article-title":"The natural history of multiple sclerosis: update 1998","volume":"18","author":"Weinshenker","year":"1998","journal-title":"Semin Neurol"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00363_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1212\/WNL.0000000000012323","article-title":"Secondary progressive multiple sclerosis: new insights","volume":"97","author":"Cree","year":"2021","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.neurot.2024.e00363_bib5","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1212\/WNL.0000000000009636","article-title":"International Advisory Committee on Clinical Trials in MS. The 2013 clinical course descriptors for multiple sclerosis: a clarification","volume":"94","author":"Lublin","year":"2020","journal-title":"Neurology"},{"issue":"Pt 9","key":"10.1016\/j.neurot.2024.e00363_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/brain\/aww173","article-title":"Defining secondary progressive multiple sclerosis","volume":"139","author":"Lorscheider","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.neurot.2024.e00363_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/13524585221114007","article-title":"Towards a validated definition of the clinical transition to secondary progressive multiple sclerosis: a study from the Italian MS Register","author":"Iaffaldano","year":"2022","journal-title":"Mult Scler"},{"issue":"10127","key":"10.1016\/j.neurot.2024.e00363_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(18)30475-6","article-title":"Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study","volume":"391","author":"Kappos","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.neurot.2024.e00363_bib9","series-title":"Interferon b-1b (Betaseron) treatment of secondary progressive forms of multiple sclerosis. Clinical review of the June 28, 2000 amendment to supplemental BLA 98-0737-STN103471: Chiron Corp","year":"2001"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00363_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1136\/jnnp-2012-303291","article-title":"Interferon beta for secondary progressive multiple sclerosis: a systematic review","volume":"84","author":"La Mantia","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00363_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines7010014","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in progressive multiple sclerosis","volume":"7","author":"Correale","year":"2019","journal-title":"Biomedicines"},{"key":"10.1016\/j.neurot.2024.e00363_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102211","article-title":"Unraveling diagnostic uncertainty in transition phase from relapsing-remitting to secondary progressive multiple sclerosis","volume":"43","author":"Carotenuto","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00363_bib13","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jamaneurol.2018.2109","article-title":"Association of inflammation and disability accrual in patients with progressive-onset multiple sclerosis","volume":"75","author":"Hughes","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurot.2024.e00363_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.549842","article-title":"Natalizumab in multiple sclerosis treatment: from biological effects to immune monitoring","volume":"11","author":"Khoy","year":"2020","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00363_bib15","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A\u00a0randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00363_bib16","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.msard.2014.08.005","article-title":"Natalizumab reduces relapse clinical severity and improves relapse recovery in MS","volume":"3","author":"Lublin","year":"2014","journal-title":"Mult Scler Relat Disord"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00363_bib17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/1352458520936239","article-title":"Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort","volume":"27","author":"Bigaut","year":"2021","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00363_bib18","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1177\/1352458512463483","article-title":"Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy","volume":"19","author":"Harrer","year":"2013","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00363_bib19","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1468-1331.2009.02532.x","article-title":"The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers","volume":"16","author":"Khademi","year":"2009","journal-title":"Eur J Neurol"},{"issue":"23","key":"10.1016\/j.neurot.2024.e00363_bib20","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1212\/WNL.0b013e3181c5b457","article-title":"Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS","volume":"73","author":"Sellebjerg","year":"2009","journal-title":"Neurology"},{"issue":"1-2","key":"10.1016\/j.neurot.2024.e00363_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2008.04.025","article-title":"Lymphoid chemokines in chronic neuroinflammation","volume":"198","author":"Aloisi","year":"2008","journal-title":"J\u00a0Neuroimmunol"},{"issue":"3","key":"10.1016\/j.neurot.2024.e00363_bib22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1352458510389102","article-title":"Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course","volume":"17","author":"Khademi","year":"2011","journal-title":"Mult Scler"},{"issue":"17","key":"10.1016\/j.neurot.2024.e00363_bib23","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.0000000000000361","article-title":"Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial","volume":"82","author":"Romme Christensen","year":"2014","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00363_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"Kapoor","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00363_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10072-018-3610-0","article-title":"The Italian multiple sclerosis register","volume":"40","author":"Trojano","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurot.2024.e00363_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.msard.2018.04.020","article-title":"Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting","volume":"24","author":"Trojano","year":"2018","journal-title":"Mult Scler Relat Disord"},{"issue":"Pt 11","key":"10.1016\/j.neurot.2024.e00363_bib27","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/brain\/awv258","article-title":"Defining reliable disability outcomes in multiple sclerosis","volume":"138","author":"Kalincik","year":"2015","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00363_bib28","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00363_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurot.2024.e00363_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/1756286419878323","article-title":"Progressive multiple sclerosis: latest therapeutic developments and future directions","volume":"12","author":"Faissner","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.neurot.2024.e00363_bib31","series-title":"Stata statistical software: release 17","year":"2021"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00363_bib32","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/brain\/awac016","article-title":"How patients with multiple sclerosis acquire disability","volume":"145","author":"Lublin","year":"2022","journal-title":"Brain"},{"issue":"9139","key":"10.1016\/j.neurot.2024.e00363_bib33","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","article-title":"Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00363_bib34","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1212\/01.WNL.0000146958.77317.3E","article-title":"North American Study Group on Interferon beta-1b in Secondary Progressive MS. Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study","volume":"63","author":"Panitch","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00363_bib35","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1212\/WNL.57.11.1969","article-title":"Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MS","volume":"57","author":"Kappos","year":"2001","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00363_bib36","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/1352458515594440","article-title":"A\u00a010-year follow-up of the European multicenter trial of interferon beta-1b in secondary-progressive multiple sclerosis","volume":"22","author":"Kuhle","year":"2016","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00363_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A\u00a0controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00363_bib38","first-page":"321","article-title":"[Responsiveness of the Expanded Disability Status Scale (EDSS) to disease progression and therapeutic intervention in progressive forms of multiple sclerosis]","volume":"51","author":"Cadavid","year":"2010","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurot.2024.e00363_bib39","first-page":"216","article-title":"Comparative pharmacokinetics and pharmacodynamics of subcutaneous and intravenous administration of natalizumab [abstract P529]","volume":"19","author":"Woodworth","year":"2013","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00363_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053297","article-title":"Impact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosis","volume":"8","author":"Cadavid","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.neurot.2024.e00363_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047578","article-title":"Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis","volume":"7","author":"Bornsen","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00363_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034103","article-title":"Long-term decrease in VLA-4 expression and functional impairment of dendritic cells during natalizumab therapy in patients with multiple sclerosis","volume":"7","author":"de Andres","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00363_bib43","doi-asserted-by":"crossref","first-page":"e869","DOI":"10.1212\/WNL.0000000000012354","article-title":"Effects of high- and low-efficacy therapy in secondary progressive multiple sclerosis","volume":"97","author":"Roos","year":"2021","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00363_bib44","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s40263-018-0530-8","article-title":"Disability outcome measures in phase III clinical trials in multiple sclerosis","volume":"32","author":"Uitdehaag","year":"2018","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00363_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000442203","article-title":"Frequency of comorbidities and their association with clinical disability and relapse in multiple sclerosis","volume":"46","author":"Tettey","year":"2016","journal-title":"Neuroepidemiology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747924000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T01:11:14Z","timestamp":1727140274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747924000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1878747924000497"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00363","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00363"}}